XLON
PRV
Market cap536mUSD
Oct 09, Last price
896.00GBP
1D
1.13%
1Q
9.00%
Jan 2017
107.17%
Name
Porvair PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment. This segment also produces a range of laboratory microplates, filters, tubing, pipette tips, and associated consumables for use in diagnostics, sample preparation and chromatography applications. The Metal Melt Quality segment designs and manufactures porous ceramic filters for the filtration of molten metals. This segment also provides patent protected filters for the aluminum cast house industry; and the filtration of gray and ductile iron, as well as filtration of superalloys used in the manufacture of turbine blades. The company is also involved in trading activities. It operates in the United Kingdom, Continental Europe, South America, the United States, Asia, and Africa, as well as other North American Free Trade Agreement countries. Porvair plc was incorporated in 1982 and is based in King's Lynn, the United Kingdom.
Key people
Hooman Javvi
Chief Executive Officer, Executive Director · since 2025
James Mills
Group Finance Director, Executive Director · since 2021
Christopher Tyler
Group Company Secretary · since 2021
Non-Executive Director · since 2025
Non-Executive Independent Chairman of the Board · since 2018
Senior Independent Non-Executive Director · since 2025
Non-Executive Independent Director · since 2023
Headquarters & legal address
7 REGIS PLACE
BERGEN WAY
KINGS LYNN, NFK PE30 2JN
GB
BERGEN WAY
KINGS LYNN, NFK PE30 2JN
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑11 | 2024‑11 | 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||